Impact on Disease Relapse of HPV Vaccination in Women Treated With LEEP for Cervical Intraepithelial Neoplasia. HOPE9
Condition: Cervical Intraepithelial Neoplasia Interventions: Biological: Gardasil-9; Drug: Placebo Sponsor: Alessandro Ghelardi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2019 Category: Research Source Type: clinical trials
Impact on Disease Relapse of Presurgical 9-valent HPV Vaccination in Women Treated With LEEP for Cervical Cancer. HOPE9
Condition: Cervical Cancer Interventions: Biological: Gardasil-9; Drug: Placebo Sponsor: Alessandro Ghelardi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2019 Category: Research Source Type: clinical trials
HPV Vaccination in Africa- New Delivery Schedules Alias The HANDS HPV Vaccine Trial
Condition: Human Papillomavirus Vaccine Interventions: Biological: 9-valent human papillomavirus vaccine (Gardasil 9) - 3 doses; Biological: 9-valent human papillomavirus vaccine (Gardasil 9) - 2 doses; Biological: 9-valent human papillomavirus vaccine (Gardasil 9) - 1 dose Sponsors: London School of Hygiene and Tropical Medicine; Public Health England; University of Cambridge; Merck Sharp & Dohme Corp. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2019 Category: Research Source Type: clinical trials
